nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Flushing—Dactinomycin—testicular cancer	0.00518	0.00518	CcSEcCtD
Nalbuphine—Hallucination—Ifosfamide—testicular cancer	0.00509	0.00509	CcSEcCtD
Nalbuphine—Bronchospasm—Etoposide—testicular cancer	0.00497	0.00497	CcSEcCtD
Nalbuphine—Sweating increased—Etoposide—testicular cancer	0.00492	0.00492	CcSEcCtD
Nalbuphine—Erythema—Dactinomycin—testicular cancer	0.00486	0.00486	CcSEcCtD
Nalbuphine—Dyspepsia—Chlorambucil—testicular cancer	0.00484	0.00484	CcSEcCtD
Nalbuphine—Flushing—Ifosfamide—testicular cancer	0.00475	0.00475	CcSEcCtD
Nalbuphine—Feeling abnormal—Chlorambucil—testicular cancer	0.00453	0.00453	CcSEcCtD
Nalbuphine—Paraesthesia—Vinblastine—testicular cancer	0.00452	0.00452	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00449	0.00449	CcSEcCtD
Nalbuphine—Bradycardia—Cisplatin—testicular cancer	0.00449	0.00449	CcSEcCtD
Nalbuphine—Injection site reaction—Epirubicin—testicular cancer	0.00449	0.00449	CcSEcCtD
Nalbuphine—Erythema—Ifosfamide—testicular cancer	0.00445	0.00445	CcSEcCtD
Nalbuphine—Urticaria—Chlorambucil—testicular cancer	0.00437	0.00437	CcSEcCtD
Nalbuphine—Abdominal pain—Chlorambucil—testicular cancer	0.00435	0.00435	CcSEcCtD
Nalbuphine—Body temperature increased—Chlorambucil—testicular cancer	0.00435	0.00435	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methotrexate—testicular cancer	0.00429	0.00429	CcSEcCtD
Nalbuphine—Confusional state—Bleomycin—testicular cancer	0.00429	0.00429	CcSEcCtD
Nalbuphine—Oedema—Bleomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Nalbuphine—Vision blurred—Ifosfamide—testicular cancer	0.0042	0.0042	CcSEcCtD
Nalbuphine—Feeling abnormal—Vinblastine—testicular cancer	0.00415	0.00415	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—testicular cancer	0.00415	0.00415	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00412	0.00412	CcSEcCtD
Nalbuphine—Flushing—Cisplatin—testicular cancer	0.00409	0.00409	CcSEcCtD
Nalbuphine—Agitation—Ifosfamide—testicular cancer	0.00409	0.00409	CcSEcCtD
Nalbuphine—Hypersensitivity—Chlorambucil—testicular cancer	0.00405	0.00405	CcSEcCtD
Nalbuphine—Hypoaesthesia—Etoposide—testicular cancer	0.00402	0.00402	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—testicular cancer	0.00402	0.00402	CcSEcCtD
Nalbuphine—Vertigo—Ifosfamide—testicular cancer	0.004	0.004	CcSEcCtD
Nalbuphine—Abdominal pain—Vinblastine—testicular cancer	0.00398	0.00398	CcSEcCtD
Nalbuphine—Hypotension—Bleomycin—testicular cancer	0.00398	0.00398	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—testicular cancer	0.00397	0.00397	CcSEcCtD
Nalbuphine—Asthenia—Chlorambucil—testicular cancer	0.00394	0.00394	CcSEcCtD
Nalbuphine—Pruritus—Chlorambucil—testicular cancer	0.00389	0.00389	CcSEcCtD
Nalbuphine—Convulsion—Ifosfamide—testicular cancer	0.00386	0.00386	CcSEcCtD
Nalbuphine—Hypertension—Ifosfamide—testicular cancer	0.00385	0.00385	CcSEcCtD
Nalbuphine—Erythema—Cisplatin—testicular cancer	0.00384	0.00384	CcSEcCtD
Nalbuphine—Paraesthesia—Bleomycin—testicular cancer	0.00382	0.00382	CcSEcCtD
Nalbuphine—Dyspnoea—Bleomycin—testicular cancer	0.00379	0.00379	CcSEcCtD
Nalbuphine—Flushing—Etoposide—testicular cancer	0.00375	0.00375	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—testicular cancer	0.00372	0.00372	CcSEcCtD
Nalbuphine—Hypersensitivity—Vinblastine—testicular cancer	0.00371	0.00371	CcSEcCtD
Nalbuphine—Muscle spasms—Cisplatin—testicular cancer	0.00369	0.00369	CcSEcCtD
Nalbuphine—Confusional state—Ifosfamide—testicular cancer	0.00367	0.00367	CcSEcCtD
Nalbuphine—Oedema—Ifosfamide—testicular cancer	0.00364	0.00364	CcSEcCtD
Nalbuphine—Vision blurred—Cisplatin—testicular cancer	0.00362	0.00362	CcSEcCtD
Nalbuphine—Asthenia—Vinblastine—testicular cancer	0.00361	0.00361	CcSEcCtD
Nalbuphine—Tremor—Cisplatin—testicular cancer	0.0036	0.0036	CcSEcCtD
Nalbuphine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00351	0.00351	CcSEcCtD
Nalbuphine—Feeling abnormal—Bleomycin—testicular cancer	0.00351	0.00351	CcSEcCtD
Nalbuphine—Vomiting—Chlorambucil—testicular cancer	0.00349	0.00349	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—testicular cancer	0.00345	0.00345	CcSEcCtD
Nalbuphine—Hypotension—Ifosfamide—testicular cancer	0.0034	0.0034	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—testicular cancer	0.00338	0.00338	CcSEcCtD
Nalbuphine—Urticaria—Bleomycin—testicular cancer	0.00338	0.00338	CcSEcCtD
Nalbuphine—Body temperature increased—Bleomycin—testicular cancer	0.00336	0.00336	CcSEcCtD
Nalbuphine—Dizziness—Vinblastine—testicular cancer	0.00333	0.00333	CcSEcCtD
Nalbuphine—Convulsion—Cisplatin—testicular cancer	0.00333	0.00333	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—testicular cancer	0.00327	0.00327	CcSEcCtD
Nalbuphine—Nausea—Chlorambucil—testicular cancer	0.00326	0.00326	CcSEcCtD
Nalbuphine—Paraesthesia—Ifosfamide—testicular cancer	0.00326	0.00326	CcSEcCtD
Nalbuphine—Anxiety—Cisplatin—testicular cancer	0.00326	0.00326	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00324	0.00324	CcSEcCtD
Nalbuphine—Dyspnoea—Ifosfamide—testicular cancer	0.00324	0.00324	CcSEcCtD
Nalbuphine—Somnolence—Ifosfamide—testicular cancer	0.00323	0.00323	CcSEcCtD
Nalbuphine—Vomiting—Vinblastine—testicular cancer	0.0032	0.0032	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—testicular cancer	0.00316	0.00316	CcSEcCtD
Nalbuphine—Headache—Vinblastine—testicular cancer	0.00316	0.00316	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—testicular cancer	0.00314	0.00314	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—testicular cancer	0.00314	0.00314	CcSEcCtD
Nalbuphine—Oedema—Cisplatin—testicular cancer	0.00313	0.00313	CcSEcCtD
Nalbuphine—Hypersensitivity—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—testicular cancer	0.00311	0.00311	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—testicular cancer	0.00309	0.00309	CcSEcCtD
Nalbuphine—Tachycardia—Cisplatin—testicular cancer	0.00306	0.00306	CcSEcCtD
Nalbuphine—Asthenia—Bleomycin—testicular cancer	0.00305	0.00305	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—testicular cancer	0.00305	0.00305	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—testicular cancer	0.00304	0.00304	CcSEcCtD
Nalbuphine—Hyperhidrosis—Cisplatin—testicular cancer	0.00303	0.00303	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—testicular cancer	0.00302	0.00302	CcSEcCtD
Nalbuphine—Pruritus—Bleomycin—testicular cancer	0.00301	0.00301	CcSEcCtD
Nalbuphine—Feeling abnormal—Ifosfamide—testicular cancer	0.003	0.003	CcSEcCtD
Nalbuphine—Nausea—Vinblastine—testicular cancer	0.00299	0.00299	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00297	0.00297	CcSEcCtD
Nalbuphine—Hypotension—Cisplatin—testicular cancer	0.00293	0.00293	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—testicular cancer	0.00292	0.00292	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—testicular cancer	0.0029	0.0029	CcSEcCtD
Nalbuphine—Urticaria—Ifosfamide—testicular cancer	0.00289	0.00289	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—testicular cancer	0.00288	0.00288	CcSEcCtD
Nalbuphine—Abdominal pain—Ifosfamide—testicular cancer	0.00287	0.00287	CcSEcCtD
Nalbuphine—Body temperature increased—Ifosfamide—testicular cancer	0.00287	0.00287	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—testicular cancer	0.00285	0.00285	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—testicular cancer	0.00283	0.00283	CcSEcCtD
Nalbuphine—Paraesthesia—Cisplatin—testicular cancer	0.00281	0.00281	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—testicular cancer	0.0028	0.0028	CcSEcCtD
Nalbuphine—Dyspnoea—Cisplatin—testicular cancer	0.00279	0.00279	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—testicular cancer	0.00278	0.00278	CcSEcCtD
Nalbuphine—Vomiting—Bleomycin—testicular cancer	0.0027	0.0027	CcSEcCtD
Nalbuphine—Depression—Methotrexate—testicular cancer	0.00269	0.00269	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—testicular cancer	0.00268	0.00268	CcSEcCtD
Nalbuphine—Rash—Bleomycin—testicular cancer	0.00268	0.00268	CcSEcCtD
Nalbuphine—Dermatitis—Bleomycin—testicular cancer	0.00268	0.00268	CcSEcCtD
Nalbuphine—Hypersensitivity—Ifosfamide—testicular cancer	0.00268	0.00268	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Nalbuphine—Asthenia—Ifosfamide—testicular cancer	0.00261	0.00261	CcSEcCtD
Nalbuphine—Feeling abnormal—Cisplatin—testicular cancer	0.00258	0.00258	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—testicular cancer	0.00258	0.00258	CcSEcCtD
Nalbuphine—Pruritus—Ifosfamide—testicular cancer	0.00257	0.00257	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—testicular cancer	0.00256	0.00256	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—testicular cancer	0.00255	0.00255	CcSEcCtD
Nalbuphine—Nausea—Bleomycin—testicular cancer	0.00253	0.00253	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—testicular cancer	0.00252	0.00252	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—testicular cancer	0.0025	0.0025	CcSEcCtD
Nalbuphine—Body temperature increased—Cisplatin—testicular cancer	0.00248	0.00248	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Nalbuphine—Dizziness—Ifosfamide—testicular cancer	0.0024	0.0024	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—testicular cancer	0.00237	0.00237	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—testicular cancer	0.00236	0.00236	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—testicular cancer	0.00235	0.00235	CcSEcCtD
Nalbuphine—Vomiting—Ifosfamide—testicular cancer	0.00231	0.00231	CcSEcCtD
Nalbuphine—Hypersensitivity—Cisplatin—testicular cancer	0.00231	0.00231	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—testicular cancer	0.00231	0.00231	CcSEcCtD
Nalbuphine—Rash—Ifosfamide—testicular cancer	0.00229	0.00229	CcSEcCtD
Nalbuphine—Dermatitis—Ifosfamide—testicular cancer	0.00229	0.00229	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—testicular cancer	0.00228	0.00228	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—testicular cancer	0.00227	0.00227	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—testicular cancer	0.00227	0.00227	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Nalbuphine—Asthenia—Cisplatin—testicular cancer	0.00225	0.00225	CcSEcCtD
Nalbuphine—Nausea—Ifosfamide—testicular cancer	0.00216	0.00216	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—testicular cancer	0.00212	0.00212	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—testicular cancer	0.00211	0.00211	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—testicular cancer	0.00206	0.00206	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Nalbuphine—Vomiting—Cisplatin—testicular cancer	0.00199	0.00199	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—testicular cancer	0.00199	0.00199	CcSEcCtD
Nalbuphine—Rash—Cisplatin—testicular cancer	0.00198	0.00198	CcSEcCtD
Nalbuphine—Dermatitis—Cisplatin—testicular cancer	0.00197	0.00197	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Nalbuphine—Tension—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—testicular cancer	0.0019	0.0019	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—testicular cancer	0.00189	0.00189	CcSEcCtD
Nalbuphine—Nausea—Cisplatin—testicular cancer	0.00186	0.00186	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—testicular cancer	0.00183	0.00183	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Nalbuphine—Rash—Etoposide—testicular cancer	0.00181	0.00181	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—testicular cancer	0.00181	0.00181	CcSEcCtD
Nalbuphine—Headache—Etoposide—testicular cancer	0.0018	0.0018	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—testicular cancer	0.00173	0.00173	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Nalbuphine—Nausea—Etoposide—testicular cancer	0.00171	0.00171	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—testicular cancer	0.00161	0.00161	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Nalbuphine—Shock—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Nalbuphine—Rash—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Nalbuphine—Headache—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Nalbuphine—Rash—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Nalbuphine—Headache—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—testicular cancer	0.000985	0.000985	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—testicular cancer	0.000956	0.000956	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—testicular cancer	0.000947	0.000947	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—testicular cancer	0.000933	0.000933	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—testicular cancer	0.000885	0.000885	CcSEcCtD
